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Abstract.  The location of autocrine interactions be- 
tween the v-sis protein and PDGF receptors remains 
uncertain and controversial.  To examine whether 
receptor-ligand interactions can occur intracellularly, 
we have constructed fusion proteins that anchor v-sis 
to specific intracellular membranes.  Fusion of a  cis- 
Golgi retention signal from a coronavirus E1 glycopro- 
tein to v-sis protein completely abolished its trans- 
forming ability when transfected into NIH3T3 cells. 
Fusion proteins incorporating mutations in this reten- 
tion signal were not retained within the Golgi complex 
but instead were transported to the cell surface, result- 
ing in efficient transformation.  All chimeric proteins 
were shown to dimerize properly.  Derivatives of some 
of these constructs were also constructed bearing the 
cytoplasmic tail from the glycoprotein of vesicular sto- 
matitis virus (VSV-G).  These constructs allowed ex- 
amination of subcellular localization by double-label 
immunofluorescence, using antibodies that distinguish 
between the extraceUular PDGF-related domain and 
the VSV-G cytoplasmic tail.  Colocalization of sis- 
E1-G with Golgi markers confirmed its targeting to 
the early Golgi complex. The sis-E1  constructs,  tar- 
geted to the early Golgi complex, exhibited no proteo- 
lyric processing whereas the mutant forms of sis-E1 
exhibited normal proteolytic processing.  Treatment 
with suramin,  a polyanionic compound that disrupts 
ligand/receptor interactions at the cell surface, was 
able to revert the transformed phenotype induced by 
the mutant sis-E1  constructs described here.  Our 
results demonstrate that autocrine interactions between 
the v-sis oncoprotein and PDGF receptors within the 
early Golgi complex do not result in functional signal 
transduction. 
Another v-sis fusion protein was constructed by at- 
taching the transmembrane domain and COOH- 
terminus of TGN38, a protein that localizes to the 
trans-Golgi network (TGN).  This construct was pri- 
marily retained intracellularly,  although  some of the 
fusion protein reached the surface.  Deletion of the 
COOH-terminal region of the TGN38 retention signal 
abrogated the TGN-localization,  as evidenced by very 
prominent cell surface localization,  and resulted in in- 
creased transforming activity. The behavior of the sis- 
TGN38 derivatives is discussed within the context of 
the properties of TGN38 itself, which is known to 
recycle from the cell surface to the TGN. 
T 
RANSFORMATION and  tumorigenesis  are  frequently 
associated with  the abnormal  expression  of growth 
factors  and  their  receptors.  Many  oncogenes  have 
been shown to be homologues of normal cellular proteins, 
as in the case of the retroviral oncogene v-sis (Devare et al., 
1983),  which is homologous with the B chain  of platelet- 
derived growth factor (PDGF) (Doolittle  et al.,  1983; Wa- 
terfield et al., 1983). Expression of the v-sis protein activates 
cellular PDGF receptors, resulting in the stimulation of sig- 
nal  transduction  pathways that  ultimately  leads to cellular 
transformation. 
Autocrine transformation  (Sporn  and Todaro,  1980) oc- 
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curs when the same cell expresses PDGF receptors as well 
as the v-sis protein. In this situation, there also exists the pos- 
sibility  of intracellular  ligand/receptor interactions  within 
the secretory pathway (Betsholtz et al., 1986). The secretory 
pathway consists of functionally  distinct  compartments,  in- 
cluding the endoplasmic reticulum (ER) and the entire Golgi 
apparatus,  consisting  of the  cis-Golgi  network,  the  cis-, 
medial-, and trans-Golgi cisternae, as well as the trans-Golgi 
network (TGN) t (Macharner,  1993; Pelham,  1991). Deter- 
mination of the site of autocrine ligand/receptor interactions 
has distinct implications  for the treatment of human cancers 
that exhibit autocrine activation of signal transduction  path- 
ways. If autocrine interactions only occur on the cell surface, 
1. Abbreviations  used in this paper: El, avian coronavirus E1 glycoprotein; 
MLV, Moloney murine leukemia virus; PDGE platelet-derived  growth fac- 
tor; TGN,  trans-Golgi  network; VSV-G, vesicular stomatitis virus glyco- 
protein. 
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with exogenous substances that disrupt these interactions. 
However,  if such interactions occur intracellularly, such as 
in the ER or the Golgi complex, then addition of such antag- 
onism will not be sufficient to revert transformation. Thus, 
it is of vital importance, both from a clinical and a molecular 
standpoint, to understand fully the mechanism and cellular 
location  of  autocrine  interactions  between  ligands  and 
receptors. 
There exists considerable controversy over the biological 
significance of intracellular interactions between v-sis and 
the PDGF-receptor. It has been demonstrated that mitogene- 
sis can be blocked in some sis-transformed  cells by treating 
them with antibodies against PDGF (Huang et al.,  1984). 
While these results indicate that cell surface interactions be- 
tween the v-sis protein and PDGF receptors are important 
in  the  transformation  process,  these  same  researchers 
demonstrated that some sis-transformed  cells did not detect- 
ably secrete v-sis protein, and anti-PDGF antibody did not 
affect transformation.  This  implies  that  an  intracellular 
mechanism  of  autocrine  transformation may  also  exist. 
Other researchers have reported that in normal cells, PDGF 
only activates receptors present on the cell surface, but that 
in sis-transformed  cells, intracellular receptors are activated 
and undergo autophosphorylation in an autocrine fashion 
(Keating and Williams, 1988; Bejcek et al., 1992). There is 
also evidence that E5,  the transforming protein of bovine 
papillomavirus,  can  interact with immature,  intracellular 
forms of PDGF receptors, stimulating their autophosphory- 
lation activity (Goldstein et al.,  1992;  Petti and DiMaio, 
1992;  Cohen et al.,  1993). 
Since receptor autophosphorylation represents a key event 
in activating PDGF-mediated signaling pathways (Williams, 
1989), these intracellular forms of the receptors may be able 
to transmit signals that lead to autocrine transformation of 
cells. However, it is not clear whether the downstream effec- 
tors of PDGF-stimulated signaling are accessible from intra- 
cellular compartments. Bejcek et al.  (1992) have demon- 
strated that internally activated receptors may associate with 
PI-3 kinase in a manner similar to mature cell surface PDGF 
receptors,  suggesting that these receptors  may indeed be 
capable of signaling from within the cell. 
Indirect methods  that  rely  upon  pharmacologic agents 
have been used by some researchers in attempts to identify 
the site of ligand/receptor interactions. Monensin has been 
shown to block transport of proteins through the trans-Golgi 
portion of the secretory pathway (Tartakoff, 1983).  Treat- 
ment of v-sis-expressing  cells with monensin prevents auto- 
phosphorylation of mature PDGF receptors and expression 
of c-fos (a nuclear protein involved in cellular growth regula- 
tion), suggesting that v-sis must be transported beyond the 
point of monensin's inhibitory activity (past the trans-Golgi 
portion) in order to activate signal transduction pathways 
(Hannink and Donoghue, 1988).  However, monensin exerts 
pleiotropic effects on cations within cells, so other cellular 
events may have been affected in these experiments. Sura- 
min, a potent inhibitor of proliferation of cells expressing 
v-sis  and PDGF  receptors,  seems  to  interfere only with 
ligand/receptor interactions at the cell surface, reducing the 
level of tyrosine-phosphorylated receptors. Suramin has lit- 
tle or no effect on intracellular phosphorylated receptors 
(Fleming et al., 1989). This suggests a requirement for cell- 
surface interactions between receptor and ligand for expres- 
sion of a transformed phenotype. However, the mechanism 
of action of surarnin is unclear, and there is evidence that it 
accumulates within endosomes (Hawking, 1978). Thus, ex- 
periments utilizing agents such as monensin or suramin have 
been viewed as problematic by some researchers. 
Therefore,  we have recently exploited more direct  ap- 
proaches to address this issue of intraceUular ligand/recep- 
tor interactions. The recent identification of specific target- 
ing and retention signals makes it possible to localize v-sis 
protein to specific intracellular compartments. This poten- 
tially allows one to scan the secretory pathway for compart- 
ments that allow functional transforming interactions be- 
tween v-sis and PDGF receptors. This represents a powerful 
approach for examining autocrine interactions, and can be 
applied to other autocrine growth factors or systems as well. 
ER-anchored forms of v-sis were previously constructed by 
this lab, using an adenovirus transmembrane protein E3/19K 
retention signal,  DEKKMP (Nilsson et al.,  1989).  These 
constructs prevented cell surface expression of v-sis protein 
as determined by immunofluorescence, and transformation 
was inhibited by retention of the fusion protein in the ER 
(Lee and Donoghue, 1992). In this report, we continued our 
analysis of autocrine transformation from within secretory 
pathway compartments by creating novel v-sis  fusion pro- 
teins targeted to unique subcellular compartments. One sig- 
nal that we chose was the cis-Golgi localization signal repre- 
sented  by  the  first  transmembrane  domain  of the  avian 
coronavirus E1 glycoprotein (El) of infectious bronchitis vi- 
rus, which has been shown by others to target heterologous 
proteins such as VSV-G and c~m (a derivative of the human 
chorionic gonadotropin-c~ subunit) to the cis-Golgi complex 
(Swift and Machamer,  1991). In addition, we chose to ex- 
ploit the TGN-localization signal of the protein TGN38, con- 
tained within its transmembrane domain and cytoplasmic 
tail, which has been shown to retarget heterologous proteins, 
such as the LDL receptor and the Tac antigen, to the TGN 
(Bos et al., 1993; Humphrey et al., 1993). The resulting sis 
fusion proteins, referred to as sis-E1 and sis-TGN38, allowed 
a further characterization of the site of autocrine interactions 
between the v-sis oncoprotein and PDGF receptors. 
Materials and Methods 
Construction of v-sis Fusion Proteins 
Plasmid pMSl50, encoding  the v-sis gene under control of  the Rous sarcoma 
virus promoter, was used as a parental clone to make the fusion proteins. 
The DNA sequence encoding amino acids 238-271  of v-sis is easily re- 
moved from pMS150 as a BstEII-ClaI fragment, allowing for insertion of 
novel sequences to create various fusion constructs. Optimized oligonucleo- 
tide synthesis and purification were as previously described (Xu et al., 
1993).  The complementary oligonucleotides for each fusion protein were 
designed so that, when annealed, 5' BstEII and 3' ClaI overhangs were pro- 
duced. Oligonucleotides were then ligated with vector DNA (pMS150) pre- 
viously digested with BstEII and ClaI and purified by agarose gel elec- 
trophoresis. Recombinant clones were recovered and the sequences of the 
oligonucleotides were confirmed by dideoxy nucleotide sequencing. 
For example, the sis-E1  contsruct required synthesis of sense and an- 
tisense oligonucleotides, designated D369 and D370, respectively. The se- 
quence of D369 is: 5'GTG.ACC.TAT.AAC.CTG.TTC.ATC.ACC.GCC.TTC. 
CTG.CTG.TTC.CTG. AC  C. ATC.  ATC.CTG.CAG.TAT.GC~.TAT.GCC.ACC. 
CGG.AGC.AAG.TAA.T  y. This oligonucleotide encodes the amino acid se- 
quence VTYNLFITAFLLFLTIILQYGYATRSK*,  where the first two amino 
acids correspond to amino acids 238 and 239 of v-sis, which lie at the BstEII 
restriction site. The remaining sequence corresponds to amino acids 21--45 
of El,  which encompasses the first transmembrane domain  (Swift and 
Machamer, 1991). Mutant versions of sis-E1, designated sis-El(Ql) and sis- 
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gonucleotides encoding sis-El(ins)  are designated I)419 and I)420 and code 
for the sequence VTYNLFITAFLIILFLTIILQYGYATRSK*  which con- 
tains an insertion of two lie residues between amino acids 29 and 30 of E1 
(shown in bold italics). The oligonucleotides encoding the other mutant, 
sis-El(Ql)  are  designated D421  and  D422  and  code  for the  sequence 
VTYNLFITAFLLFLTIIL1YGYATRSK*  which  contains  a  mutation  of 
Glu37 to lie (shown in bold italics). 
Similar constructs were also designed to encode an extended cytoplasmic 
tail derived from VSV-G.  The oligonucleotides encoding sis-E1-G  were 
designated D455 and D456. The sense strand oligonucleotide I)455 encodes 
the amino acid sequence VTYNLFITAFLLFLTIILQYGYATRVGIHLCIK- 
LKHTKKRQIYTDIEMNRLGK*. The first 25 amino acids are the same as 
in the sis-El construct, but the final 28 originate from the COOH-terminus 
of the VSV-G protein, sis-EI(QI)-G and sis-El(ins)-G were constructed in 
the same manner. 
The final constructs utilize the transmembrane domain and cytoplasmic 
tail of TGN38.  sis-TGN38  was encoded by oligonucleotides D496  and 
D497.  The sense strand oligonucleotide D496 encodes the amino acid se- 
quence VTESSHFFAYLVTAAVLVAVLYIAYHNKRKIIAFALEGKRSKV- 
TRRPKASDYQRLNLKL* Again the first two amino acids correspond to 
238  and 239 of v-sis,  and the remaining 57  amino acids correspond to 
residues 284-340 of TGN38,  encoding the transmembrane domain and cy- 
toplasmic tail of this protein. A mutant version, sis-TGN38A,  was also con- 
structed using oligonncleotides 13498 and D499.  These oligonucleotides 
encode a  truncated version of the sequence shown above: VTESSHFFA- 
YLVTAAVLVAVLYIAYHNKRS*  and with the final  amino acid changed 
from a lysine to a serine. 
The parental vector contains an XhoI restriction site just upstream of the 
v-sis coding sequence. For use in transfection and infection of NIH3T3 
cells, DNA fragments encoding the above described v-sis-fusion proteins 
were subcloned as XhoI-ClaI restriction fragments into the murine leuke- 
mia virus (MLV) expression vector pMS177,  which was derived from the 
previously  described  retroviral  vector  pDD102  (Bold  and  Donoghue, 
1985). 
Focus Formation Assays and Infection Protocol 
NIH3T3  cells were maintained at 370C,  10%  COz in DME containing 
10%  calf serum, fed every 3 d with fresh medium, and passaged when 
70-80% confluent. For focus assays, cells were split at a density of 2  x 
10  s cells per 60-ram plate and transfected the following day with 50 ng of 
expressing plasmid, 50 ng pZAP helper virus (Hoffman et al., 1982),  and 
9.9 t~g carrier plasmid DNA using the calcium phosphate precipitation pro- 
tocol (Chen and Okayanm,  1987). Cells were incubated with precipitate for 
18-20 h at 37°C, 3%  CO2,  then refed and transferred to  10% CO2.  The 
cells from each 60-mm plate were split 1:12 the following day and scored 
for foci 4-5 d later. 
For infections, NIH3T3 ceils were transfected as described above with 
9/~g of MLV DNA plus 1/~g pZAP helper virus. Transfected cells were 
split as described above, and allowed to grow for 4 d without refeeding. The 
supernatant media,  containing viral particles, were then collected, cen- 
trifuged to pellet any cells, and used to infect monolayers of fresh NIH3T3 
cells, split 1-2  x  10  s cells per 60-ram plate one day earlier. Polybrene (4 
#g/ml) was added to the newly infected cells to increase the efficiency of 
infection. Infected cells were refed the following day with fresh DME me- 
dia, and were used 2 or 3 d later for labeling and intmunoprecipitations or 
immunofluorescence. This protocol results in a very high percentage of  cells 
expressing the desired protein. 
Metabolic Labeling and Immunoprecipitations 
NIH3T3 cells were subjected to the infection protocol described above.  3 
or 4 d after infection with viral supernatants, cells were incubated for 15 
rain in MEM lacking cysteine and methionine. Each plate was labeled with 
35  35  100/~Ci  [  S]Met and [  S]Cys in 0.5 rnl MEM minus cysteine and methio- 
nine for 2 h. Calls were lysed with 1.0 rnl radioimmunnprecipitation assay 
buffer (10 mM sodium phosphate, pH 7.2,  150 mM NaC1,  1% NP-40, 1% 
DOC, 0.1% SDS, 10/~g/ml Aprotinin), clarified by centrifugation, and in- 
cuhated with a  rabbit antiserum directed against bacterially synthesized 
v-sis protein, generously provided by Ray Sweet and Keith Deen (Smith, 
Kline and French, King of  Prussia, PA) for 2 h at 4°C with rotation. Protein 
A-Sepharose beads (Sigma Chemical Co., St.  Louis, MO) preincubated 
with unlabeled NIH3T3 cell lysate were used to isolate immune complexes. 
After separation on a sucrose gradient and extensive washing in radioim- 
munoprecipitation assay buffer,  the beads were treated with 2×  sample 
buffer,  and immunoprecipitates were separated on a  15%  SDS-PAGE gel 
and detected by fluorography. For analysis of dimer formation, half of each 
sample was treated with reducing sample buffer (50 mM Tris, pH 6.8, 2 % 
SDS, 20%  2-mercaptoethanol,  10%  glycerol), while the other half was 
resuspended in nonreducing sample buffer which lacked the 2-mercapto- 
ethanol. The samples were run on the same 15%  SDS-PAGE gel and de- 
tected as described above. 
Indirect Immunofluorescence 
NIH3T3 cells were grown on coverslips and transfected as described above 
with 10 t~g of Rous sarcoma virus constructs, or subjected to infection with 
viral supernatants (see above). To detect intracellniar v-sis fusion proteins, 
ceils were fixed in 3 % paraformaldehyde/PBS for 10 rnin, followed by per- 
meabilization in 1% Triton/PBS for 5 rain. Cells were then incubated with 
a  rabbit  antiserum  directed  against  the  v-sis  protein,  followed by  a 
rhodamine-conjugated goat anti-rabbit antibody. To detect cell surface v-sis 
fusion proteins, cells were fixed with paraformaldehyde and incubated with 
antibodies without permeabilization, as described previously (Hannink and 
Donoghue, 1986a;  Lee and Donoghue, 1992). 
For double-labeling experiments to detect expression of both intracellu- 
lar and cell surface fusion proteins, cells were fixed as described above, 
then treated with a rabbit antibody to v-sis, then with rhodamine-conjugated 
goat anti-rabbit antibody.  The same cells were then permeabilized and 
treated with 10/~g/rnl  of mAb P5D4 (Kries and Lodish, 1986) against the 
COOH  terminus of VSV-G  (kindly  made  available  by  William  Balch, 
Scripps Clinic and Research Foundation, La Jolla, CA). These intracellular 
proteins were detected with a biotin-conjugated goat anti-mouse antibody 
which was in turn detected by FITC-conjugated streptavidin. For colocaliza- 
tion experiments, NIH3T3 cells grown on coverslips were infected with vi- 
ral supernatants derived from sis-El-G-expressing cells, Coverslips were 
fixed and permeabilized as described above, and sis-E1-G was detected with 
a-sis  antibody  and  rhodamine-conjugated  goat  anti-rabbit  IgG,  For 
colocaiization  with  the  lectin,  cells  were  then  incubated  with  FITC- 
conjugated Lens culinaris  lectin  (Sigma).  For  colocalization with mAb 
10E6, cells were then incubated with 10E6 mAb, which was detected with 
FITC-conjngated goat anti-mouse IgG (kindly provided by V.  Malhotra 
[Univ.  California, Davis,  CA] and W. J.  Brown [Cornell Univ., Ithaca, 
NY)). 
Suramin Treatment of Transformed Cells 
NIH3T3 cells were transfected  as described above with 9 #g of  MLV expres- 
sion constructs plus 1 /~g pZAP helper virus. Cells from individual foci 
were isolated with cloning rings and transferred to 24-well plates with tryp- 
sin, and allowed to grow for 2-3 d, refeeding after 1 d. The cells were tryp- 
sinized, transferred to 60-mm plates, then 1 d later split 1:4 to two 10-cm 
plates, and the following day treated with media with or without 100 #M 
suramin. Cells were examined for morphological changes after 24 h. 
In Vitro Kinase Assay 
NIH3T3  cells were transfected with 9/~g of MLV constructs plus  1 #g 
pZAP, and supernatants collected and used for infection of fresh NIH3T3 
cells. 2 d after infection, the 60 mm plates of ceils were serum starved in 
DME for 24 h, then treated for 5 rain with 100 ng/ml PDGF-BB (Amgan, 
Thousand Oaks,  CA) or left untreated.  Cells were lysed in NP-40 lysis 
buffer (20 mM Tris, pH 7.5, 137 mM NaCI,  1% NP-40,  1 mM sodium or- 
thovanadate, 5 mM EDTA,  10 t~g/ml Aprotinin, and  10%  glycerol) and 
scraped from plates with rubber policemen. The lysates were clarified by 
centrifugation, then incubated for 2 h with a rabbit antiserum specific for 
the mouse PDGF-B receptor (Upstate Biotechnology Inc., Lake Placid, 
NY). Immune complexes were collected with protein A-Sepharose beads, 
spun through a  10%  sucrose in NP-40 lysis buffer solution, washed twice 
with NP-40 lysis buffer, and once with 20 mM Tris, pH 7.5. 40 t~l of kinase 
buffer (20 mM Tris,  pH 7.5,  10 mM MnCI2, 10 mM MgCI2) containing 5 
#Ci ['y-32P]ATP was then added to the beads, and reactions were incubated 
for 10 min at 37°C. Reaction products were separated by SDS-PAGE (7.5 %) 
and visualized by autoradiography. 
Results 
Construction of  Plasmids Encoding Golgi-localized 
Derivatives of v-sis 
Fig.  1 depicts the orientation and organization of the fusion 
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localized v-sis derivatives. All 
constructs  used  the  first 239 
amino acids of the v-sis pro- 
tein, which includes: a signal 
sequence;  a  pmpeptide with 
N-linked  oligosaccharide  ad- 
dition site and dibasic proteo- 
lytic processing  site; and the 
82-amino  acid  MTR.  The 
sis-G-ER  +  and  sis-G-ER- 
constructs  were produced  by 
fusing  a  known  ER  reten- 
tion  signal (DEKKMP)  or a 
scrambled signal (DEMPKK) 
from  an  adenoviral  protein, 
E3/19K, onto the cytoplasmic 
end of sis-G fusions (lee and 
Donoghue,  1992). The  next 
six  constructs  contain 
residues 21-45 of El, a glyco- 
protein  from  an  avian 
coronavirus.  These  residues 
encode  the  first  transmem- 
brahe  domain  of El,  which 
has been shown to confer cis- 
Golgi  localization.  The  last 
three constructs in the E1 set 
have a 39-amino acid section 
of  the glycoprotein G from the 
vesicular  stomatitis  virus 
(VSV-G) fused  to  the  cyto- 
plasmic  tail.  The  mutant 
forms  of  these  constructs, 
sis-El(QI)  and  sis-El(ins), 
should  abolish  the  signal's 
Golgi-retention  capabilities. 
The final two constructs have 
a section of TGN38, a TGN- 
localized  protein,  encoding 
the  transmembrane  domain 
and  C-terminal  tail  (amino 
acids 284-340)  fused to v-sis. 
A mutant form was made by 
truncating  the  cytoplasmic 
tail region, and thus uses only 
amino  acids  284-311  of 
TGN38. This construct should 
not be retained intracellularly. 
proteins constructed for these experiments. The first three 
constructs,  sis-G,  sis-G-ER +,  and  sisG-ER-,  were  de- 
scribed previously (Lee and Donoghue,  1992),  and served 
as a basic model for the construction of these new fusion pro- 
teins. In all cases, the first 239 amino acids of v-sis are in- 
cluded in the fusion proteins. This portion of v-sis provides 
a signal sequence, a dibasic proteolytic processing site, and 
the 82-amino acid minimal transforming region (Hannink 
and Donoghue, 1986b; Sauer et al., 1986; Giese et al., 1987; 
Sauer and Donoghue,  1988).  All constructs are in Type I 
orientation-the NH2 terminus is "out; and the COOH ter- 
minus "in" 
The sis-E1  fusion incorporates a 25-amino acid segment 
of the avian coronavirus E1  protein,  containing  the entire 
first transmembrane domain of E1  and a short cytoplasmic 
tail. This region has been shown to confer localization of E1 
to  the  cis-Golgi  cisternae,  allowing  for  assembly  of the 
coronavirus to occur at intracellular membranes (Swift and 
Machamer,  1991;  Machamer et al.,  1990).  When incorpo- 
rated into heterologous proteins, this E1 transmembrane do- 
main  can  function  as  a  cis-Golgi  localization  signal,  as 
shown by incorporation of this transmembrane domain into 
fusion proteins  with  VSV-G and am  (a human  chorionic 
gonadotropin/VSV-G fusion protein) (Swift and Machamer, 
1991). The sis-El(QI) construct incorporates a mutation that 
changes Gin 37 to fie, and this mutation abolishes correct 
localization  (Swift and  Machamer,  1991).  The sis-El(ins) 
construct  contains  an  insertion  of two lie  residues  in  the 
transmembrane domain, which similarly abolishes cis-Golgi 
localization. The sis-E1-G constructs are quite similar to the 
above, but they have an extended COOH-terminal domain 
provided by a portion of the G protein from VSV-G (Rose and 
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label immunofluorescence  experiments to be performed, and 
does not significantly  alter the localization efficiency  or func- 
tion of the fusion proteins, as described below. 
The membrane-anchor region of sis-TGN38 consists of 59 
amino acids, containing the transmembrane domain and cy- 
toplasmic tail of TGN38,  a Type I-oriented protein which 
was isolated from rat liver Golgi membranes (Luzio et al., 
1990) and is normally localized to the TGN (Ladinsky and 
Howell,  1992;  Bos et al.,  1993;  Reaves  et al.,  1993).  A 
tyrosine-containing motif, Tyr-Gln-Arg-Leu (YQRL), in the 
COOH-terminal domain of  TGN38, has been shown to be es- 
sential for TGN localization (Bos et al., 1993; Humphrey et 
al., 1993; Wong and Hong, 1993). This motif  has also been 
shown to be sufficient for localizing heterologous proteins, 
such as the LDL receptor and the Tac antigen (interleukin-2 
receptor A-chain) to the TGN (Bos et al., 1993; Humphrey 
et al., 1993). A mutant version of the sis-TGN38 construct, 
referred to as sis-TGN38A, was constructed using only the 
28 amino acids of TGN38 that encompass the transmem- 
brane domain. Thus, the sis-TGN38A construct lacks the es- 
sential tyrosine-containing motif, and should not be retained 
in the TGN. 
The sis-E1 Fusion Proteins Are Unable to Cause 
Cellular Transformation 
The transforming ability of the various v-sis fusion proteins 
was  assayed by transfection of NIH3T3  cells using MLV- 
based retroviral constructs (Bold and Donoghue, 1985). The 
relative ability to transform cells was based on the number 
of foci formed, with both positive and negative (mock) con- 
trois for comparison. The same amount of DNA was trans- 
fected for each construct, and the number of foci formed was 
normalized to the activity of the positive control, sis-G. As 
shown in Table I, cells transfected with sis-E1 or sis-E1-G 
exhibited negligible transforming activity, comparable to the 
mock-transfected cells. The presence of  the VSV-G cytoplas- 
mic tail in the sis-E1-G construct seemed to have little or no 
effect on  its  transforming activity.  Thus,  addition of the 
retention signal of the E1 protein abrogated the transforming 
potential of v-sis, presumably by localizing virtually all of 
the fusion protein to an intracellular location incapable of 
autocrine stimulation. 
In contrast, all of the derivatives that incorporated muta- 
tions  in  the  E1  localization signal,  including sis-El(Q1), 
sis-El(Q1)-G,  sis-El(ins),  and  sis-El(ins)-G,  exhibited 
transformation with efficiencies ranging from '~25-50%  of 
sis-G (Table I). These fusion proteins were consistently less 
transforming the sis-G, but this phenomenon has been ob- 
served before in our lab, with other membrane-anchored de- 
rivatives of v-sis (Hannink and Donoghue, 1986a;  Lee and 
Donoghue, 1991; Xu et al., 1993). This may result from the 
fact that these membrane-anchored ligands are restricted in 
their ability to diffuse, and thus less likely to activate recep- 
tors as efficiently as the native secreted protein. 
The sis-TGN38 Fusion Protein Causes Inefficient but 
Detectable Cellular Transformation 
Focus assays were also performed by transfecting NIH3T3 
cells with the sis-TGN38 and sis-TGN38A constructs. Table 
I shows that, when fused to a portion of TGN38 containing 
the  TGN-localization  signal,  v-sis  can  interact  with  the 
PDGF receptor to result in autocrine transformation with an 
efficiency of 32%  of the sis-G control. The mutant deriva- 
five, sis-TGN38A, which lacks the tyrosine-containing TGN 
localization signal, was consistently more active in transfor- 
marion assays, exhibiting 55 % as many foci as the sis-G con- 
trol.  Recently, it was  demonstrated that TGN38  recycles 
from the TGN to the cell surface (Reaves et al., 1993). This 
observation complicates our results,  in that we are at this 
point unable to determine if  the transforming potential of the 
sis-TGN38 fusion protein is due to a subpopulation of  protein 
molecules present on the cell surface at any given time, or 
whether it is truly mediated by ligand/receptor interactions 
occurring  within the  TGN.  Further  experiments  will  be 
needed to clarify this. 
Dimerization of the Fusion Proteins 
To verify that the constructs used in this study were capable 
of encoding the desired proteins, the coding regions from 
each construct were swapped  into a  pSP64(polyA) vector 
(Promega Biotec, Madison, WI) for in vitro transcription 
and translation experiments. Messenger RNA was synthe- 
sized  (Melton,  1987) and translation reactions were per- 
formed in rabbit reticulate lysate in the presence of [35S]Cys. 
SDS-PAGE  analysis  of  the  products  of  these  reactions 
demonstrated proteins  with  molecular  weights  that  cor- 
related with the expected sizes of each of the fusion proteins 
(data not shown). This indicates that our constructs encode 
the desired fusion proteins. 
Table 1.  Properties  of Golgi-localized  sis-derivatives 
Localization  by IF 
Origin of  Origin of  Predicted 
Construct  TM domain  cyto tail  location  Permeabilized  Non-perm.  Transformation 
sis-E1  IBV E1  -  cis-Golgi  ER/early-Golgi  -  0.6% 
sis-El(ins)  IBV E1  -  Surface  ER/Golgi  Surface  27% 
sis-El(Q1)  IBV E1  -  Surface  ER/Golgi  Surface  34% 
sis-E1-G  IBV E1  VSV-G  cis-Golgi  ER/early-Golgi  -  0.7% 
sis-El(ins)-G  IBV E1  VSV-G  Surface  ER/Golgi  Surface  25% 
sis-El(Q1)-G  IBV E1  VSV-G  Surface  ER/Golgi  Surface  49% 
sis-TGN38  TGN38  TGN38  TGN  Golgi  Surface (weak)  32% 
sis-TGN38A  TGN38  A  Surface  Goigi  Surface  55 % 
Transformation efficiency for each construct is shown as a percentage of the positive control sis-G. Data shown is from a single experiment, which was repeated 
at least three times with similar results. 
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sis-E1-G chimeric proteins are not able to cause transforma- 
tion. The most likely explanation is that these proteins are 
anchored in a cellular compartment where they are unable 
to functionally interact with PDGF receptors. However, one 
might postulate other explanations for the lack of transform- 
ing activity exhibited by these proteins. For example, a criti- 
cal post-translational event may be altered by forcing v-sis to 
remain intracellular, thereby abolishing its activity. N-linked 
glycosylation of  v-sis is not required for its biological activity 
(Sauer et al.,  1986),  and bacteriaUy-expressed PDGF-BB 
(which has no N- or O-linked glycosylation) is biologically 
active  (Hoppe  et  al.,  1989).  Therefore,  glycosylation of 
v-sis, although altered in these fusion proteins, does not con- 
stitute  a  critical  processing  event.  However,  v-sis  must 
dimerize in order to function (Hannink et al., 1986), so per- 
haps these fusion proteins do not dimerize correctly. To ad- 
dress this, we infected NIH3T3 cells with viral supernatants 
collected from cells transfected with the indicated v-sis fu- 
sion constructs (see legend to Fig. 2).  The fusion proteins 
were immunoprecipitated using the a-sis antibody, and one 
half of the  sample  was  treated with  nonreducing  sample 
buffer to examine dimeric proteins, while the other half was 
treated with reducing sample buffer to examine monomeric 
forms. Fig. 2, lanes 3 and 9 shows  that the sis-E1  chimera 
indeed dimerizes, yielding a dimer band of •62-64  kD un- 
der nonreducing conditions, and a 32-kD monomer band un- 
der reducing conditions.  Comparison of the left and right 
panels of  Fig. 2 further illustrates that all of  the chimeric pro- 
teins dimerize as expected, indicating that this critical pro- 
cessing event is not altered in the fusion proteins. Thus, these 
data suggest that the transforming activity of the v-sis fusion 
proteins described here most closely correlates with their 
subcellular localization within the cell, as verified further 
below, rather than resulting from differences in posttransla- 
tional processing events. 
Fusion Proteins Are Synthesized and Are Processed 
According to SubceUular Location 
Like most other secreted proteins, v-sis undergoes a variety 
of posttranslational modifications as it passes through the 
secretory  pathway. One of  these processing events is cleavage 
at a dibasic site to release the propeptide region of the pro- 
tein. This is thought to occur late in the secretory pathway, 
between the trans-cistemae of the Golgi complex and the 
plasma membrane (Robbins et al.,  1985; Lokeshwar et al., 
1990).  Thus, sis-E1  and sis-El-G,  if retained in the early 
Golgi complex, should not undergo this processing step. The 
mutant  versions  of  these  two  fusion  proteins,  however, 
should reach the cell surface and thus should exhibit process- 
ing  of this propeptide.  Similarly,  the sis-TGN38  and sis- 
TGN38A  fusion proteins both  should  exhibit processing, 
since these should be either retained in a compartment that 
is past the site of this modification, or be present on the cell 
surface. 
To examine proteolytic processing of our fusion proteins, 
NIH3T3 cells expressing the desired proteins were metaboli- 
cally labeled with [35S]Cys and [35S]Met, and labeled pro- 
teins  were  immunoprecipitated and  separated  by  SDS- 
PAGE. As shown in Fig. 3, the sis-E1-G protein showed no 
detectable processed forms (Fig. 3, lane 2), implying reten- 
tion in an early Golgi compartment. On the other hand, the 
mutant derivatives sis-El(Ql)-G and sis-El(ins)-G both ex- 
hibited processing, which appears as a doublet of lower mo- 
Figure 2.  SDS-PAGE analysis of dimers of v-sis fusion proteins. 
Equivalent numbers of NIH3T3 ceils expressing various v-sis fu- 
sion proteins were labeled for 2 h with 100 ~Ci each [35S]Cys  and 
[35S]Met. Cell lysates were immunoprecipitated with an antibody 
directed against v-sis. One-half of  the sample was treated with non- 
reducing sample buffer, to visualize dimers, while the remaining 
half was treated with reducing sample buffer (containing 2-mercap- 
toethanol), to visualize monomers. Samples were analyzed by 15 % 
SDS-PAGE followed  by fluorography.  The arrows indicate the posi- 
tion of dimer and monomer bands, respectively, of v-sis fusion pro- 
teins. Molecular mass markers in kD are indicated at the fight. 
Lanes 1 and 7, mock-infected cells; lanes 2 and & sis-G; lanes 3 
and 9, sis-El; lanes 4 and I0, sis-El-G; lanes 5 and 11, sis-El(ins)-G; 
and lanes 6 and 12, sis-I~3N38. Exposure time was 3 d. 
Figure 3. SDS-PAGE  analysis 
of  immunoprecipitated  pro- 
teins encoded by Golgi-local- 
ized v-sis-derivatives. Equiva- 
lent numbers of NIH3T3 cells 
expressing  various  v-sis  fu- 
sion proteins were labeled for 
2  h  with  100  ~tCi each 
[35S]Cys and  [35S]Met. Cell 
lysates were immunoprecipi- 
tared  with  an  antibody 
directed against v-sis and ana- 
lyzed by 15 % SDS-PAGE  fol- 
lowed by  fluorograpby. The 
arrows  indicate  the  position 
of  proteolytically  processed 
v-sis  fusion  proteins.  Mo- 
lecular  mass markers  in kD 
are  indicatr~l  at  the  fight. 
Lane 1,  mock-infected cells; 
lane  2,  sis-El-G;  lane  3, 
sis-El(ins)-G;  lane  4,  sis- 
EI(Q/)-G.  Exposure time to 
show the processed bands was 
2 d for the top half  of  the figure, 
and 8 d fur the bottom half. 
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rows).  Similar results were obtained using the constructs 
lacking the G tail (data not shown). The diffuse signal above 
the  major bands  most likely represents  heterogeneity of 
O-linked oligosaccharides which, although previously ob- 
served (Lee and Donoghue, 1992), have not been extensively 
characterized. In summary, these results are consistent with 
localization of sis-E1 and sis-E1-G to the early Golgi com- 
plex, whereas the proteins encoded by the other constructs 
have clearly progressed through the secretory pathway be- 
yond the trans-Golgi  complex. 
Cleavage of the propeptide region of v-sis is not required 
for its activity, as demonstrated initially in previous work 
from this laboratory in which the Lys-Arg cleavage  site of 
v-sis was mutated to Asn-Ser with no change in biological 
activity (Saner et al., 1986). In subsequent studies from our 
lab, the KR to NS mutation has been incorporated into a va- 
riety  of  membrane-anchored  derivatives  (Hannink  and 
Donoghue,  1986b;  Lee and Donoghue,  1992;  Xu  et al., 
1993),  including sis-G and sis-G-ER-, with no effect on bi- 
ological activity. This is an important point, as the constructs 
that are retained in the early Golgi, sis-E1  and sis-El-G, 
would not be expected to undergo this cleavage process. 
Thus, we can conclude that the inactivity of these proteins 
is not due to their lack of propeptide cleavage. 
Cell Surface Expression Is Detectable in sis-E1 
Mutants and sis-TGN38 Derivatives 
To examine the subcellular location of v-sis fusion proteins, 
NIH3T3 cells were transfected with MLV expression con- 
structs  and then processed  for immunofluorescence. The 
proteins were detected by an antibody to the v-sis portion of 
the fusion proteins. As visualized in the permeabilized cells 
shown in Fig. 4, there was a high level of expression for all 
the fusion proteins presented in this figure (see Fig. 4, A, C, 
E, and G). Staining can be seen of the ER and Golgi of these 
cells,  indicating  the  presence  of  these  fusion  proteins 
throughout the secretory compartment. The cells depicted in 
Fig. 4 are representative of the positive cells seen in these 
transient expression assays. The percentage of cells express- 
ing the desired constructs typically ranged from ,,ol-5 %. 
Surface staining of nonpermeabilized cells was readily de- 
tectable for cells expressing sis-El(ins), sis-El(Ql), and sis- 
TGN38A derivatives (see Fig. 4, B, D, and H), indicating 
that these fusion proteins are efficiently transported to the 
cell surface, as expected. The sis-TGN38 construct (F) dis- 
plays decreased but detectable surface staining, indicating 
that a portion of the population of this protein reaches the 
cell surface. This is consistent with the behavior of native 
TGN38, which has been shown to recycle between the TGN 
and the cell surface (Reaves  et al.,  1993).  Since a  small 
amount of this sis-q'GN38 fusion protein reaches the cell sur- 
face, this may explain the transforming activity of this con- 
struct in the focus formation assays (see Table I). However, 
at this time we have no way of determining if the TGN- 
retained population of the fusion protein contributes in any 
way to the transforming activity. 
The sis-E1-G Fusion Protein Is Efficiently Retained 
within the Cell 
While Fig. 4 clearly demonstrates that the sis-E1 mutants 
and the sis-TGN38 derivatives reach the cell surface, it does 
not answer the question of whether the sis-E1 or sis-E1-G fu- 
sions do not reach the surface. To address this question, 
double-label immunofluorescence was performed using the 
constructs bearing the VSV-G cytoplasmic tail. This allowed 
for simultaneous examination of both intracellular and cell 
surface populations of the various fusion proteins within the 
same cell. Cell surface protein was detected with an antibody 
against v-sis. The cells were then permeabilized, and intra- 
cellular fusion proteins were detected with a monoclonal an- 
tibody to the VSV-G protein. As positive controls, both the 
sis-El(ins)-G and the sis-El(Ql)-G fusion proteins were in- 
cluded in this assay. As in Fig. 4, Fig. 5 shows that these pro- 
teins were readily detected within the cell (E and G) as well 
as on the cell surface (F and H). As another control, sis-G 
was included. This fusion protein was created in our lab for 
previous experiments, and it localizes to the cell surface 
(Hannink and Donoghue, 1986a).  A and B of Fig. 5 clearly 
demonstrate both intracellular and surface staining for this 
construct. C demonstrates the reticular and perinuclear in- 
tracellular staining consistently seen for sis-El-G, indicating 
presence of this protein within the ER and Golgi complex. 
When looking for sis-E1-G  protein on the surface of the 
same cell, D demonstrates that there is no detectable surface 
staining. As with Fig. 4, these were transient expression as- 
says, and the typical percentage of cells expressing the trans- 
fected fusion constructs was ,,ol-5 %. We deliberately exam- 
ined cells expressing high levels of protein within the cell, 
so that even weak cell surface staining would be detectable. 
Although deliberate selection of high-expressing  cells tended 
to obscure any detail present in the permeabilized cells, the 
issue of whether sis-E1 and sis-E1-G are in fact localized to 
the early Golgi complex is addressed in colocalization ex- 
periments in the subsequent section. The cell featured in Fig. 
5 is representative of all sis-El-G-expressing cells, in that 
we were never able to detect protein on the cell surface. 
Thus, the cis-Golgi retention signal of the E1 glycoprotein, 
when appended to the v-sis protein, results in efficient reten- 
tion of the fusion protein to an intracellular compartment. 
Colocalization with Golgi Markers Confirms 
the Targeting of  sis-E1-G 
To  demonstrate that sis-E1  and  sis-E1-G  fusion proteins 
are indeed targeted to the early Golgi complex, we have 
used double-label immunofluorescence to colocalize these 
chimeric proteins with known Golgi markers.  The Golgi 
markers used were (a) Lens culinaris lectin, a carbohydrate- 
binding protein that binds to terminal o~-mannosyl and o~-D- 
glucosyl residues  (Kornfeld et  al.,  1981), and  has  been 
shown to stain primarily the Golgi complex of cells (Hsu et 
al., 1992; Machamer et al., 1993); and (b) a monoclonal an- 
tibody 10Et, described by Wood et al.  (1991), which was 
localized to the cis-Golgi complex of NRK cells by immuno- 
electron microscopy. In these studies, the sis-E1-G chimera 
was expressed in NIH3T3 cells by infection with retroviral 
supernatants, and was detected in fixed and permeabilized 
cells with a polyclonal rabbit antisera to v-sis.  This in turn 
was visualized with a rhodamine-conjugated goat anti-rabbit 
IgG. To visualize the Golgi complex, these same cells were 
treated with either a fluorescein-conjugated Lens culinaris 
lectin, or with the mouse mAb 10E6, which was visualized 
with a fluorescein-conjugated  goat anti-mouse IgG. The two 
cells shown for each condition in Fig. 6 are representative 
Hart et al. Golgi Localization of v-sis Oncoprotein  1849 Figure 4. Intracellular  and cell 
surface  localization  of  v-sis 
fusion  proteins.  Immuno- 
fluorescence  was  performed 
on permeabilized cells (A, C, 
E, and G) and nonpermeabi- 
lizcd cells (B, D, F,, and H) ex- 
pressing  various  v-sis  fusion 
proteins.  Proteins  were  de- 
tected with a rabbit antiserum 
specific  for  the v-sis  protein 
and  a  rhodamine-conjugated 
goat anti-rabbit  secondary an- 
tibody. A and B, sis-El(ins);  C 
and  D,  sis-El(Ql);  E  and  F,, 
sis-TGN38;  G  and  H, 
sis-TGN38A. 
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nofluorescence  allows  for si- 
multaneous examination of in- 
tracellular  and  cell  surface 
expression  of fusion proteins. 
Cells  expressing  various  fu- 
sion proteins  were processed 
for immunofluorescence.  Sur- 
face proteins were detected by 
a rabbit serum directed against 
the v-sis protein,  and rhoda- 
mine-conjugated  goat  anti- 
rabbit antibody (B, D, F, and 
H). Intrac~llular proteins were 
detected  by  a  mouse  mAb 
against  the  COOH-terminal 
portion of the VSV-G protein 
and  a  biotin-conjugated  goat 
anti-mouse antibody, followed 
by FITC-conjugated streptavi- 
din(A, C, E, and G). A and B, 
sis-G,  C and D, sis-El-G;  E 
and F, sis-El(ins)-G;  G and 
H, sis-El(QI)-G. 
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pressing  the  sis-E1-G fusion  protein  were  processed  for  im- 
munofluorescence. The fusion protein was detected by a rabbit se- 
rum directed against the v-sis protein, and rhodamine-conjugated 
goat anti-rabbit antibody (A, C, E, and G). To simultaneously de- 
tect the  Golgi  complex,  cells  were  then  incubated with  either 
fluorescein-conjugated Lens culinaris lectin (B and D), or mAb 
10E6 plus fluorescein-conjugated goat anti-mouse IgG (F and H). 
of the sis-El-G-expressing cells generated in these immu- 
nofluorescence assays.  The percentage of ceils expressing 
protein was higher using this infection protocol than that ob- 
tained  by  transient  transfections.  This  percentage  varied 
from •10-15  %. As Fig. 6 shows, the sis-E1-G fusion protein 
clearly colocalizes with both the lectin (see A and B, C and 
D) and the mAb  10E6 (see E  and F,  G and H). Thus, the 
E1 cis-Golgi targeting signal functions correctly and targets 
v-sis  to the early Golgi when incorporated into  a  fusion 
protein. 
Suramin Reverts the Transformed Phenotype of  sis-E1 
Mutants and sis-TGN38 Constructs 
Suramin  is  a  polysulfonated naphthylurea  derivative  re- 
ported to inhibit PDGF mitogenic activity and to revert the 
v-sis transformed phenotype (Betsholtz et al.,  1986).  It is 
postulated to exert this effect  by disruption of  ligand-receptor 
interactions that occur on the cell surface. This mechanism 
of action is supported by the ability of suramin to reduce the 
level of tyrosine-phosphorylated cell surface PDGF recep- 
tors, while having no effect on the levels of tyrosine phos- 
phorylation  of  the  intracellular,  immature  forms  of  the 
receptors (Fleming et al.,  1989).  Since suramin has been 
shown to accumulate intraceUularly (Hawking,  1978;  La- 
Rocca et al., 1990), it may also be possible for it to interfere 
with intracellular interactions between receptor and ligand 
(Huang and Huang,  1988). 
To further examine the mechanism of transformation oc- 
curring in our cells, we treated NIH3T3 cells expressing the 
transforming constructs with  suramin to  see  if the trans- 
formed phenotype would revert in its presence. Transformed 
cells  expressing  sis-El(Ql),  sis-El(ins),  sis-q~3N38, sis- 
TGN38A, and v-sis as a positive control, were examined in 
the absence of suramin (Fig. 7, A, C, E, G, and I), or in the 
presence of suramin (Fig. 7, B, D, F, H, and J). In all cases, 
suramin did indeed revert the phenotype. It has been shown 
that E5, an oncoprotein derived from the bovine papillomavi- 
rus, can interact with immature intracellular forms of PDGF 
receptors, and may stimulate their autophosphorylation ac- 
tivity (Goldstein et al.,  1992; Petti and DiMaio,  1992; Co- 
hen et al., 1993). It has also been shown by Xu et al. (1993) 
that BPV-E5-transformed cells do not revert in the presence 
of suramin. Thus, cells transformed by E5 were included as 
a  negative control in  the suramin  reversion assay.  As  ex- 
pected,  the presence of suramin  did not affect the trans- 
formed phenotype of NIH3T3 cells expressing E5 (Fig. 7, K 
and L). These results indicate that the productive transform- 
ing interactions between PDGF receptors and the v-sis fu- 
sion proteins described here are occurring  in  a  suramin- 
sensitive site, most likely the cell surface. 
Downregulaaon  of  PDGF-[3 Receptors Does 
Not Occur in Response to IntraceUularly Retained 
Fusion Proteins 
A normal response in cells that are chronically exposed to 
PDGF is the downregulation of PDGF receptors (Garrett et 
al.,  1984).  This downregulation occurs via endocytosis of 
Arrows indicate regions of each cell that stain positively for both 
the sis-E1-G fusion protein and the Golgi complex. 
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fected NIH3T3 cells expressing v-sis fusion proteins were starved 
for 24 h in DME media minus calf serum, then treated with  100 
ng/ml PDGF-BB for 5 min (A, lanes 1-9) or left untreated (B, lanes 
1-9). Receptors were immunoprecipitated with a rabbit antiserum 
directed against mouse PDGF-/~ receptors, and subjected to kinase 
reactions. Products were analyzed by SDS-PAGE  and autoradiogra- 
phy. A and B, lane  1 uninfected NIH3T3 ceils; A and B, lane 2, 
mock-infected ceils; A and B, lane 3, sis-E1; A and B, lane 4, sis- 
El(ins); A and B, lane 5, sis-El(Ql); A and B, lane 6, sis-TGN38; 
A and B, lane 7, sis-TGN38A; A and B, lane 8, sis-G; lane 9, sis-G- 
ER  +. Molecular mass markers are indicated in kD. The arrow in- 
dicates the position of the PDGF-/3 receptor. 
receptors from the cell surface and subsequent degradation. 
To analyze if such a process occurred in cells expressing any 
of the v-sis fusion proteins described in this paper, PDGF-/3 
receptors  were  immunoprecipitated  from  serum-starved 
cells expressing the  fusion proteins  either before or after 
stimulation with PDGF-BB. These receptors were then sub- 
jected to an in vitro kinase assay, and incorporation of la- 
beled phosphate from [3,-32P]ATP into the receptor protein 
was visualized by SDS-PAGE. As seen in Fig. 8, in the ab- 
sence  of stimulation  with  PDGF,  little  or  no  activatable 
receptors were detected  (B,  lanes  1-9).  After  stimulation 
with PDGF-BB, however, NIH3T3 cells,  mock-transfected 
cells, and cells expressing sis-E1  all exhibited a  significant 
level of cell surface activatable receptors (A, 1-3), as demon- 
strated by the phosphorylation of PDGF-# receptors of ~180 
kD. Expression of the mutant sis-El(Ql) and sis-El(ins) con- 
structs, which reach the cell surface, led to downregulation 
of cell surface activatable receptors, and thus there was little 
detectable kinase activity in these samples (Fig. 8A, lanes 4 
and 5). Similar results were obtained with sis-TGN38,  sis- 
TGN38A and v-sis,  which also reach the cell surface (Fig. 
8/1, lanes 6,  7, and 8). These results demonstrate that when 
v-sis is forced to remain in an intracellular compartment, 
such as the early Golgi, it is unable to downregulate cell sur- 
face PDGF receptors. 
Figure  7. Suramin treatment reverts the transformed phenotype of 
cells expressing cell-surface  fusion proteins.  For each construct, 
the left panel shows cells in the absence of suramin (A,  C, E, G, 
I, and K), while the fight panel shows cells after 24-h treatment 
with  100  /~M  suramin  (B,  D,  F,  H,  J,  and  L).  A  and  B,  sis- 
El(ins)-G; C and D, sis-El(Ql)-G; E and F, sis-TGN38;  G and H, 
sis-TGN38A; 1 and J, v-sis; K and L, BPV-E5. 
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Retention of the v-sis oncogene in the early Golgi complex 
by means of a transmembrane retention signal abolishes its 
transforming ability, as demonstrated by a dramatic decrease 
in focus forming activity. All fusion proteins constructed for 
these experiments dimerized properly, indicating that this 
critical post-translational modification of the v-sis portion of 
the fusions was not altered. The fusion proteins sis-E1 and 
sis-E1-G  were  efficiently retained  intracellularly, as  evi- 
denced by the lack of  proteolytic processing of  the constructs 
and lack of downregulated cell surface PDGF  receptors. 
Immunofluorescence  data are consistent with Golgi localiza- 
tion of the sis-E1  and sis-E1-G constructs.  Colocalization 
with Lens culinaris lectin and mAb 10E6 confirm targeting 
to the early Golgi complex of the sis-E1 and sis-E1-G  con- 
structs.  Mutant derivatives of the these constructs, contain- 
ing defects in the cis-Golgi localization signal, were not re- 
tained inside the cell and were transforming. These proteins 
were proteolytically  processed as expected, and were detect- 
able on the cell surface by immunofluorescence. Suramin 
reverted  the  transformation induced by these  latter  con- 
structs, providing further evidence that functional interac- 
tions between v-sis and PDGF receptors occur primarily on 
the cell surface. The results obtained with the sis-E1 and sis- 
E1-G constructs indicate that the intracellular compartment 
of the early Golgi complex does not allow for autocrine acti- 
vation of PDGF receptors. 
Attempts to retain v-sis protein in a more distal Golgi re- 
gion by attachment of a TGN retention signal yielded ambig- 
uous results. While most of  the sis-TGN38 fusion protein was 
retained intracellulady, some of  the protein was able to reach 
the cell surface, as shown by immunofluorescence. Indeed, 
it has been demonstrated recently that TGN38 actually recy- 
cles from the cell surface and back to the TGN (Reaves et 
al., 1993). It is likely that this population of molecules that 
reached the cell surface was responsible for the transforma- 
tion seen in the focus assays in cells expressing this fusion 
protein,  since treatment with suramin reverted the trans- 
formed phenotype. However,  we cannot conclusively rule 
out the possibility that functional autocrine interactions can 
occur in the TGN. Significantly, however, when the COOH- 
terminus of the TGN38-derived domain was truncated, the 
transforming efficiency of the derivative sis-TGN38A nearly 
doubled (Table I). This data certainly provides a correlation 
between transformation and increased cell surface localiza- 
tion, compared with TGN localization. 
Previous Evidence for IntraceUular 
Autocrine Interactions 
Since v-sis-transformed ceils express both v-sis protein and 
PDGF receptors, there exists the possibility that these two 
proteins can interact as they pass simultaneously through the 
secretory pathway. Keating and Williams (1988) reported the 
detection of PDGF receptors that are activated intracellu- 
larly in v-sis-transformed cells. These receptors were of an 
immature form, as determined by their molecular mass (160 
kD)  and lack of glycosylation (Huang and Huang,  1988; 
Keating and Williams, 1988), and are rapidly degraded after 
stimulation by v-sis (Keating and Williams, 1988; Bejcek et 
al.,  1992).  High concentrations of antisera to PDGF were 
shown to be unable to reverse transformation of NRK cells. 
Also, high levels of exogenously added v-sis protein have not 
been shown to cause transformation of NRK cells (Bejcek et 
al., 1989). Both of these observations suggest that an intra- 
cellular autocrine mechanism may exist.  These same re- 
searchers  attached a  six-amino acid  ER-retention signal, 
SEKDEL, to the v-sis protein and observed morphological 
transformation of cells expressing this fusion protein.  No 
secreted fusion protein was detectable. Bejcek and cowork- 
ers (1992) also have shown that v-sis, but not endogenously 
expressed PDGF-A homodimers, can activate PDGF recep- 
tors intracellularly; thus the capacity of v-sis to act intracel- 
lularly may underlie its mechanism of transformation. 
Evidence for a Post-endoplasmic Reticulum Location 
for Autocrine Interactions 
The KDEL retention signal used by Bejcek et al. (1989) has 
since been shown to be a retrieval signal-not a true reten- 
tion signal-allowing for return of escaped proteins to the 
ER (Pelham, 1991). There is also evidence that this signal 
allows some leakage of  proteins to the cell surface (Zagouras 
and Rose, 1989).  Thus, the finding that v-sis can transform 
cells with this KDEL signal attached most likely indicates 
that an undetectable amount of the fusion protein was able 
to escape the ER to a more distal location, such as the cell 
surface, where productive autocrine interactions occurred. 
If protein was secreted, it likely was rapidly internalized by 
receptor-mediated endocytosis, and thus escaped detection. 
Indeed, we have experienced difficulty  in immunoprecipitat- 
ing and detecting wild-type v-sis protein in transformed cells 
due to this rapid internalization (data not shown). 
A different  ER retention signal has been identified by Nils- 
son et al. (1989) from the adenovirus protein E3/19K. Lee 
and Donoghue (1992) appended this signal to the COOH ter- 
minus of the v-sis  protein and demonstrated that (a)  the 
retention signal effectively retained v-sis in the ER, with no 
leakage to the cell surface as confirmed by immunofluores- 
cence, and (b) this ER-retained form of v-sis was no longer 
able to transform NIH3T3 cells in an autocrine fashion. This 
evidence suggests that v-sis cannot productively  interact with 
the PDGF receptor within this compartment. 
Support  for Localization of  Autocrine v-sis/PDGF 
Receptor Interactions Beyond the Trans-Goigi 
Hannink and Donoghue (1988) constructed an inducible au- 
tocrine system in NIH3T3 cells by placing the v-sis gene un- 
der control of the hsp70 heat shock promoter, allowing for 
induction of v-sis expression by a short incubation at 45°C. 
With this system, they demonstrated that productive inter- 
actions  between  v-sis  and  PDGF  receptors  occur  in  a 
monensin:insensitive site. Since monensin acts by disrupting 
the structure and function of the trans-Golgi complex, and 
reduces the rate of transport of proteins to the cell surface 
(Tartakoff,  1983),  these results indicate that transformation 
only results when v-sis interacts with receptors in a region 
past the trans-Golgi  complex. However,  since monensin is 
a pleiotropic agent, there may have been other effects on the 
cells that were not taken into account. Also, the temperature 
shock required for induction of the hsp70 promoter may have 
induced other endogenous heat shock proteins. 
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v-sis-transformed  cells reverts the transformed phenotype 
(Fleming et al.,  1989),  and that suramin decreases phos- 
phorylation levels of cell-surface PDGF receptors with little 
effect on intracellular receptor phosphorylation. These ex- 
periments suggest that v-sis protein can interact with intra- 
cellular forms of the PDGF receptors in cells and stimulate 
autophosphorylation activity of these immature receptors, 
but that activated receptors must reach a suramin-sensitive, 
cell surface location in order to trigger the signal transduc- 
tion cascade that leads to transformation. 
Previous experiments by Lee and Donoghue (1992) sug- 
gested that the ER compartment of the secretory pathway 
does not support transforming interactions between v-sis and 
PDGF-R.  One reason that the sis-G-ER ÷ construct could 
not productively interact with PDGF-R could be that either 
the ligand or the receptors had not yet undergone critical 
posttranslational modifications required for functional inter- 
actions and signal transduction. Such modifications may oc- 
cur in the Golgi portion of the secretory pathway,  partic- 
ularly  modifications  of N-linked  oligosaccharide  or  the 
addition  of  O-linked  oligosaccharide  which  are  largely 
confined to the later Golgi compartments. We have previ- 
ously demonstrated that, except for disulfide bond formation 
which occurs in the ER very shortly after translation, further 
posttranslational modifications are not required for the bio- 
logical activity of the v-sis protein (Hannink et al.,  1986; 
Hannink  and  Donoghue,  1986b;  Sauer  and  Donoghue, 
1988).  However,  extensive  oligosaccharide  addition  and 
modification to PDGF-R occurs, and its importance is not 
clear (Keating and Williams, 1987).  Use of an early Golgi 
retention signal-the first transmembrane domain of the E1 
glycoprotein-allowed us to begin to investigate possible au- 
tocrine interactions within the  Golgi region by retaining 
v-sis as a fusion protein in this compartment. This retention 
of the v-sis oncoprotein within the early Golgi complex com- 
pletely abrogated its transforming ability, and thus we con- 
clude that productive autocrine interactions cannot occur in 
the early secretory pathway. 
Localization of v-sis to the TGN by means of a retention 
signal derived from TGN38 resulted in decreased levels of 
transforming ability. However, immunofluorescence data in- 
dicate that a small portion of this sis-TGN38 fusion protein 
was able to reach the cell surface, a finding that is consistent 
with reports by Reaves et al. (1993) that TGN38 recycles be: 
tween the TGN and the cell surface. Suramin treatment of 
cells expressing sis-TGN38 leads to reversion of the trans- 
formed phenotype, further implicating a cell surface pool of 
sis-TGN38 in the transformation of these cells. However, we 
are unable to conclusively determine from these experiments 
that v-sis targeted to the TGN is not transforming. Currently, 
we are undertaking studies which should further clarify in- 
teractions within the late Golgi compartments. These new 
studies utilize a similar approach of constructing fusion pro- 
teins, this time using the transmembrane domains and cy- 
toplasmic tails of well-characterized glycosyltransferases, 
which are  resident Golgi enzymes.  These membrane an- 
chors should give tighter retention in the later Golgi com- 
partments than seen with the TGN38-derived retention sig- 
nal,  and will hopefully provide  a  conclusive indication of 
whether v-sis is able to engage in productive autocrine inter- 
actions within the late Golgi complex. 
Why Might sis Be Unable to Transform 
from an IntraceUular Compartment? 
While it has been established that immature forms of the 
PDGF-R can be stimulated by v-sis to undergo phosphoryla- 
tion within the secretory pathway (Hannink and Donoghue, 
1988; Keating and Williams, 1988; Bejcek et al., 1992), the 
question remains-are these interactions functional? That is, 
does this simple intracellular interaction between v-sis and 
PDGF-R contribute to acquisition of the transformed pheno- 
type? One argument against this possibility is that the down- 
stream effector molecules, such as PLC-3, (Kumjian et al., 
1989;  Meisenhelder et ai.,  1989;  Wahl et al.,  1989;  Mor- 
rison et al., 1990), PI-3 kinase (Coughlin et ai., 1989; Kaz- 
lauskas and Cooper,  1989),  ras-GAP (Kaplan et al.,  1990; 
Kazlauskas et al., 1990),  and others, that normally interact 
with activated PDGF-R at the plasma membrane may not be 
available to the immature activated receptors present within 
the  secretory  pathway.  The  evidence  from Bejcek et al. 
(1992) that indicates the intracellularly phosphorylated, im- 
mature forms of the receptor are capable of interacting with 
PI-3 kinase in 3T3 cells begins to address the functionality 
of intracellular v-sis/PDGF  receptor interactions, but far 
from answers the question. Future studies in our lab will be 
aimed at examining the availability of such effector mole- 
cules within the secretory pathway, and whether they can in- 
deed be activated intracellularly. These studies will include 
attempts to retarget some members of  the signal transduction 
machinery to the early Golgi complex, to see if this will then 
allow sis-E1 or sis-E1-G to signal from this compartment. 
The results of these future studies should provide significant 
insight into the mechanisms of autocrine transformation. 
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